A Cohort Study of Early Chronic Obstructive Pulmonary Disease for China Pulmonary Health Study Stage II
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 400
- 试验地点
- 6
- 主要终点
- FEV1 annual decline in clinical practice
研究概览
简要总结
Discovery of the pathogenesis and targets in the progression of early chronic obstructive pulmonary disease
详细描述
This project is aimed to investigate and explore the heterogeneity during the progression of Chronic Obstructive Pulmonary Disease (COPD) in the early stage, utilizing the large-scale population cohort databases (including "China Pulmonary Health study", "The Cohort Study for Chronic Obstructive Pulmonary Disease in China" and "Acute Exacerbation of COPD Patient Registry in China" ), biological sample libraries(including blood, sputum, expiratory air, bronchoalveolar lavage fluid(BALF), and lung tissue from COPD patients with different stages and phenotypes), and multi-omics sequencing (including scRNA-seq, metabolomics, proteomics, and metagenome). We propose to establish a new standard for COPD stages and subtypes. By analyzing and mining the multi-omics data, it is expected to illustrate the association between clinical phenotype and molecular, cellular and tissue heterogeneities, thus reveal biomarkers related to the progression, clinical phenotypes, and prognosis of early-stage COPD disease.In addition, we will construct different types and stages of COPD animal models for further mechanism studies, such as the different pathogenic factors, innate and adaptive immunity, and the airway microbial ecosystem, so that we can discovered more potential therapeutic target for early-stage COPD. This project can bring a new insight and scientific evidence for COPD treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 50 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •younger than 50 years
- •smoking more than 10 pack-years
- •early airflow limitation(post-bronchodilator FEV1/FVC< lower limit of normal)
排除标准
- •other respiratory diseases
- •mental illness
结局指标
主要结局
FEV1 annual decline in clinical practice
时间窗: 2021.1-2024.12
FEV1 measured by portable spirometry can reflect the progression of early COPD.
次要结局
- dyspnea symptoms(2021.1-2024.12)
- frequency of COPD acute exacerbation(2021.1-2024.12)
- chest imaging changes(2021.1-2024.12)
- systemic complications(2021.1-2024.12)
研究者
Chen Wang
Study Chair
China-Japan Friendship Hospital
